An image of a pen, a magnifying glass, a calculator and a laptop on a table
Markets

Boxer Capital, LLC Buys AveXis, BeiGene, Alnylam Pharmaceuticals, Sells Biomarin ...

Boxer Capital, LLC

  • New Purchases: ALNY , ALXN , SBBP , SNSS, BLPH, RXDX,
  • Added Positions:AVXS, BGNE, MDCO,
  • Reduced Positions:SGEN, CLVS, ARDM,
  • Sold Out:BMRN, RIGL, HRTX, EBIO, EPIX,

For the details of Boxer Capital, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Boxer+Capital%2C+LLC

These are the top 5 holdings of Boxer Capital, LLC

  1. AveXis Inc ( AVXS ) - 1,028,763 shares, 20.71% of the total portfolio. Shares added by 243.20%
  2. Clovis Oncology Inc ( CLVS ) - 850,000 shares, 15.93% of the total portfolio. Shares reduced by 15%
  3. The Medicines Co ( MDCO ) - 828,198 shares, 11.86% of the total portfolio. Shares added by 18.31%
  4. BeiGene Ltd ( BGNE ) - 850,000 shares, 10.88% of the total portfolio. Shares added by 72.19%
  5. Blueprint Medicines Corp ( BPMC ) - 705,159 shares, 8.34% of the total portfolio.

New Purchase: Alnylam Pharmaceuticals Inc (ALNY)

Boxer Capital, LLC initiated holdings in Alnylam Pharmaceuticals Inc. The purchase prices were between $31.41 and $70.3, with an estimated average price of $41.87. The stock is now traded at around $47.02. The impact to the portfolio due to this purchase was 3.95%. The holdings were 250,000 shares as of 2016-12-31.

New Purchase: Alexion Pharmaceuticals Inc (ALXN)

Boxer Capital, LLC initiated holdings in Alexion Pharmaceuticals Inc. The purchase prices were between $110.01 and $135.59, with an estimated average price of $122.36. The stock is now traded at around $130.39. The impact to the portfolio due to this purchase was 3.87%. The holdings were 75,000 shares as of 2016-12-31.

New Purchase: Strongbridge Biopharma PLC (SBBP)

Boxer Capital, LLC initiated holdings in Strongbridge Biopharma PLC. The purchase prices were between $2.3 and $5.4, with an estimated average price of $4.08. The stock is now traded at around $2.45. The impact to the portfolio due to this purchase was 0.95%. The holdings were 940,000 shares as of 2016-12-31.

New Purchase: Sunesis Pharmaceuticals Inc (SNSS)

Boxer Capital, LLC initiated holdings in Sunesis Pharmaceuticals Inc. The purchase prices were between $3.49 and $4.71, with an estimated average price of $3.98. The stock is now traded at around $4.10. The impact to the portfolio due to this purchase was 0.8%. The holdings were 525,000 shares as of 2016-12-31.

New Purchase: Bellerophon Therapeutics Inc (BLPH)

Boxer Capital, LLC initiated holdings in Bellerophon Therapeutics Inc. The purchase prices were between $0.47 and $1.48, with an estimated average price of $0.93. The stock is now traded at around $0.91. The impact to the portfolio due to this purchase was 0.41%. The holdings were 1,857,143 shares as of 2016-12-31.

New Purchase: Ignyta Inc (RXDX)

Boxer Capital, LLC initiated holdings in Ignyta Inc. The purchase prices were between $4.25 and $7.1, with an estimated average price of $5.83. The stock is now traded at around $9.55. The impact to the portfolio due to this purchase was 0.28%. The holdings were 125,000 shares as of 2016-12-31.

Added: AveXis Inc ( AVXS )

Boxer Capital, LLC added to the holdings in AveXis Inc by 243.20%. The purchase prices were between $42 and $71.36, with an estimated average price of $53.44. The stock is now traded at around $59.36. The impact to the portfolio due to this purchase was 14.68%. The holdings were 1,028,763 shares as of 2016-12-31.

Added: BeiGene Ltd ( BGNE )

Boxer Capital, LLC added to the holdings in BeiGene Ltd by 72.19%. The purchase prices were between $26.95 and $36.9, with an estimated average price of $31.43. The stock is now traded at around $40.78. The impact to the portfolio due to this purchase was 4.56%. The holdings were 850,000 shares as of 2016-12-31.

Sold Out: Biomarin Pharmaceutical Inc (BMRN)

Boxer Capital, LLC sold out the holdings in Biomarin Pharmaceutical Inc. The sale prices were between $78.62 and $95.92, with an estimated average price of $86.

Sold Out: Rigel Pharmaceuticals Inc (RIGL)

Boxer Capital, LLC sold out the holdings in Rigel Pharmaceuticals Inc. The sale prices were between $2.38 and $4.01, with an estimated average price of $2.86.

Sold Out: Heron Therapeutics Inc (HRTX)

Boxer Capital, LLC sold out the holdings in Heron Therapeutics Inc. The sale prices were between $12.4 and $20.35, with an estimated average price of $15.69.

Sold Out: Eleven Biotherapeutics Inc (EBIO)

Boxer Capital, LLC sold out the holdings in Eleven Biotherapeutics Inc. The sale prices were between $1.41 and $2.92, with an estimated average price of $2.2.

Sold Out: ESSA Pharma Inc (EPIX)

Boxer Capital, LLC sold out the holdings in ESSA Pharma Inc. The sale prices were between $1.8 and $2.73, with an estimated average price of $2.18.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLVS BGNE BPMC

Other Topics

Stocks

Latest Markets Videos